Improved clinical competence - tearing down the barriers to market for a unique in vitro diagnostic

Important results from the project

The MedTech4Health project has allowed Celluminova to acquire competences and tools needed for successful customer interactions for our in vitro diagnostic product, GlioStem-B. We will continue to build on this competence as the company grows with the aim that our product shall provide a much needed tool for neurosurgeons and, with time, benefit patients with malignant glioma.

Expected long term effects

** Denna text är maskinöversatt ** The MedTech4Health project has led to increased clinical competence of Celluminova´s staff and thus increased opportunities to initiate clinical collaborations and set up well-designed clinical studies that benefit both Celluminova, surgeons and, most importantly, the patients.

Approach and implementation

** Denna text är maskinöversatt ** The project has been carried out together with a consultant and has taken place through training, discussions and own work. Celluminova is very satisfied with both the project and the collaboration.